ARDX peer analysis
Ardelyx (ARDX) against its competitors: price, today's move, 1-year return and market value side by side.
ARDX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AKBA Akebia Therapeutics | $0.71 | 0.27% | -67.95% | $195.78M |
| DMAC DiaMedica Therapeutics | $9.29 | 0.43% | 31.59% | $498.81M |
| MAZE Maze Therapeutics | $30.37 | -3.53% | -7.72% | – |
| XERS Xeris Biopharma | $10.17 | -5.04% | 4.85% | $1.95B |
| ARDX Ardelyx | $3.03 | 0.00% | -50.00% | $782.31M |
- ARDX's peers: AKBA (Akebia Therapeutics), DMAC (DiaMedica Therapeutics), MAZE (Maze Therapeutics), XERS (Xeris Biopharma).
Updated 2026-11-03 11:32 UTC